Enveda announced positive Phase I results of its drug ENV-308, which mimics a molecule naturally produced during exercise.

There’s a lot of interest swirling around new clinical data about the ENV-308 pill. Here’s what doctors say ...

It’s totally different from a GLP-1. Here’s what you need to know.

Touting an “exceptional” gastrointestinal safety profile for its oral obesity drug candidate in a study of healthy volunteers ...

Company hopeful the drug can help people maintain weight loss and muscle mass without the digestive issues many experience on ...

The idea of getting some of exercise’s benefits from a pill has hovered somewhere between serious medicine and science ...

Envestnet, Inc. ENV has had an impressive run in the past month. The stock has gained 12.4%, outperforming the 5.5% rise of the industry it belongs to and the 4.3% growth of the Zacks S&P 500 ...

BOULDER, Colo., August 18, 2026--1 in 8 US adults are reported to use GLP-1 medications, but the majority of people who ...

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...